NCT02064816
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- Please contact the Merck KGaA Communication Center Darmstadt, Germany
Clinical trial condition
Explore clinical trials studying Multiple Sclerosis, Relapsing-Remitting. Study availability and eligibility vary by location and protocol.
NCT02064816
NCT03679806
NCT02652091
NCT02506751
NCT02598167
NCT02410200
NCT01431937
NCT01466322
NCT01416363
NCT00071838